Evidence map›Paper›PMID 31285784›Full record

ArticleOxidative medicine and cellular longevity2019

The Effect of 600 mg Alpha-lipoic Acid Supplementation on Oxidative Stress, Inflammation, and RAGE in Older Adults with Type 2 Diabetes Mellitus.

Víctor Manuel Mendoza-Núñez, Beatriz Isabel García-Martínez, Juana Rosado-Pérez, Edelmiro Santiago-Osorio, José Pedraza-Chaverri, Vicente Jesús Hernández-Abad

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05808946 (The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05808946 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis

TypeinterventionalSponsorAin Shams UniversityRan2023 to 2024Enrolled60ConditionsSepsisArmsAlpha-Lipoic Acid, Sepsis Supportive Care
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. The effect of alpha-lipoic acid supplementation on vascular function and inflammation in patients newly experienced stroke.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Current Strategies for the Management of Painful Diabetic Neuropathy.Journal of diabetes science and technology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Víctor Manuel Mendoza-NúñezResearch Unit on Gerontology, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-9137-3405
Beatriz Isabel García-MartínezResearch Unit on Gerontology, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-1815-3537
Juana Rosado-PérezResearch Unit on Gerontology, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-6147-7502
Edelmiro Santiago-OsorioHematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-4876-0688
José Pedraza-ChaverriDepartment of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM), Mexico City 04510, Mexico.ORCID 0000-0001-6628-4411
Vicente Jesús Hernández-AbadPharmaceutical Research Laboratory, FES Zaragoza, National Autonomous University of Mexico, Mexico City, Mexico.
Universidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-lipoic acid (ALA) has been used as a dietary supplement at different doses in patients with diabetes mellitus type 2 (T2DM) due to its antioxidant, anti-inflammatory, and hypoglycemic effects. However, the reports on the effects of ALA are controversial. For this reason, the purpose of the present study was to determine the effect of 600 mg/day of ALA on the markers of oxidative stress (OxS) and inflammation and RAGE in older adults with T2DM. A quasiexperimental study was carried out with a sample of 135 sedentary subjects (98 women and 37 men) with a mean age of 64 ± 1 years, who all had T2DM. The sample was divided into three groups: (i) experimental group (EG) with 50 subjects, (ii) placebo group (PG) with 50 subjects, and control group (CG) with 35 subjects. We obtained the following measurements in all subjects (pre- and posttreatment): glycosylated hemoglobin (HbA1c), receptor for advanced glycation end products (RAGE), 8-isoprostane, superoxide dismutase (SOD), glutathione peroxidase (GPx), total antioxidant status (TAS), and inflammatory (CRP, TNF-

Indexed as

AgedAntioxidantsBlood GlucoseBlood PressureChromatography, High Pressure LiquidC-Reactive ProteinDiabetes Mellitus, Type 2Energy IntakeFemaleGlutathione PeroxidaseHumansInflammationMaleMiddle AgedOxidative StressReceptor for Advanced Glycation End ProductsAntioxidantsBlood GlucoseC-Reactive ProteinGlutathione PeroxidaseReceptor for Advanced Glycation End ProductsSuperoxide DismutaseThioctic Acid

Identifiers

PMID31285784
PMCPMC6594273
OpenAlexW2953095737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.